• Redefining Cell Death Detection: AO/PI Staining in Translati

  2026-06-24

  This thought-leadership article explores the transformative role of the AO/PI Double Staining Kit in deciphering cell viability and death mechanisms in complex translational models. By integrating mechanistic insights, benchmark data, and guidance for organoid and cancer research, it offers a forward-looking strategy for researchers aiming to bridge foundational cell biology with clinical innovation.

• Busulfan: DNA Alkylating Agent for Germ Cell Depletion Model

  2026-06-23

  Busulfan is a DNA alkylating agent used for precise germ cell depletion and senescence induction in research models. Its action involves DNA crosslinking and activation of MAPK pathways, with defined solubility profiles and workflow protocols. Recent genetic tracing studies clarify its limits and applications in reproductive biology.

• n-Dodecyl-β-D-maltoside: Enabling Membrane Protein Purificat

  2026-06-23

  n-Dodecyl-β-D-maltoside (DDM) is redefining how researchers solubilize, stabilize, and functionally analyze challenging membrane proteins. This article distills workflow advances, troubleshooting expertise, and protocol enhancements—anchored by the WecA system and APExBIO’s DDM—for robust, reproducible membrane protein studies.

• Spatially Targeted mTORC1 Inhibition Reveals Nuclear Transcr

  2026-06-22

  The reference study introduces a genetically encoded mTORC1 inhibitor, TerminaTOR, to selectively interrogate the function of mTORC1 at distinct subcellular locations. This innovation uncovers nuclear mTORC1's direct role in regulating transcription of CCAAT motif-containing genes, defining spatial compartmentalization as a critical determinant of mTORC1 function and opening new avenues for targeted pathway research.

• HotStart Universal 2X FAST Green qPCR Master Mix: Precision

  2026-06-22

  The HotStart Universal 2X FAST Green qPCR Master Mix enables rapid, reproducible gene expression analysis, even in the presence of challenging inhibitors such as those found in blood samples. Its unique hot-start Taq polymerase and dual dye system streamline melt curve validation and compatibility across all qPCR platforms, empowering advanced biofilm research and beyond.

• ICG001: Advanced Wnt/β-Catenin Inhibition for Regenerative R

  2026-06-21

  Explore how ICG001, a potent Wnt/β-catenin pathway inhibitor, is revolutionizing the study of stem cell modulation, cancer biology, and tissue regeneration. This article uniquely bridges high-precision mechanistic insight with translational applications, grounded in the latest peer-reviewed findings.

• Berberine Suppresses SASP via RXRα/PPARγ/NEDD4 in Atheroscle

  2026-06-20

  A recent study elucidates how berberine counteracts senescence-associated secretory phenotype (SASP)–driven inflammation in atherosclerosis by activating the RXRα/PPARγ/NEDD4 axis in macrophage-derived foam cells. These findings clarify molecular events underpinning chronic vascular inflammation and identify actionable targets for anti-aging therapy.

• Ranolazine in Cardiac Ischemia Research: Applied Workflows &

  2026-06-19

  Ranolazine empowers researchers to dissect cardiac and hepatic metabolism with precision, thanks to its dual modulation of sodium currents and metabolic pathways. This guide details robust experimental workflows, practical troubleshooting, and the translational impact of Ranolazine in advanced cardiac ischemia and metabolic studies.

• KU-55933: ATM Kinase Inhibitor for Advanced DDR Workflows

  2026-06-19

  KU-55933 empowers researchers to dissect the DNA damage response with nanomolar precision, enabling robust cell cycle arrest and metabolic interrogation in cancer models. Discover workflow optimizations, troubleshooting tactics, and cross-study insights that elevate ATM kinase inhibition to a new standard in experimental reproducibility.

• SMC2 and SMC4 as Prognostic Markers in Breast Cancer

  2026-06-18

  This study identifies SMC2 and SMC4 as independent prognostic markers in breast cancer using integrated bioinformatics and experimental analyses. The results highlight their roles in tumor progression, therapy response, and potential utility for guiding future research and clinical strategies.

• β-Pseudouridine: Mechanistic Leverage for Dose-Sparing RNA V

  2026-06-18

  This thought-leadership article explores how β-pseudouridine—the C-glycoside isomer of uridine—transforms RNA vaccine design. By weaving mechanistic insight with actionable protocol guidance, we dissect how this modification stabilizes RNA structures, enhances translational fidelity, and enables dose-sparing breakthroughs in self-amplifying RNA (saRNA) platforms. Drawing on recent comparative immunogenicity studies and referencing APExBIO’s β-pseudouridine, we chart a roadmap for translational researchers aiming to optimize next-generation RNA therapeutics.

• iPSC-Derived Platforms Advance Cystic Fibrosis Drug Testing

  2026-06-17

  This study introduces a multimodal induced pluripotent stem cell (iPSC) platform for modeling cystic fibrosis (CF) using patient-specific airway epithelial cells. By adapting functional assays to these iPSC-derived cells, the research provides a scalable approach for evaluating CFTR modulators across diverse genetic backgrounds, offering new avenues for precision drug development.

• 3D Nanotube-Micropillar Electrodes Enable Size-Independent B

  2026-06-17

  This study introduces a robust three-dimensional nanotube-in-micropillar electrode platform that overcomes cell size heterogeneity barriers in non-viral blood cell electroporation. By enabling high-efficiency mRNA and plasmid delivery across diverse blood cell types, the approach advances safer, more versatile gene therapy protocols.

• RNA Pol II Inhibition Triggers Apoptosis via Active Signalin

  2026-06-16

  Harper et al. (2025) demonstrate that cell death resulting from RNA Pol II inhibition is not due to passive loss of transcription but is instead driven by an active apoptotic pathway triggered by the loss of hypophosphorylated RNA Pol IIA. This mechanistic insight reshapes our understanding of apoptosis and provides new directions for research on cell death and therapeutic targeting.

• 10074-G5 c-Myc Inhibitor: Applied Cancer Research Workflows

  2026-06-16

  10074-G5 is a potent c-Myc inhibitor enabling precise disruption of oncogenic transcriptional networks in advanced cancer models. This article delivers actionable workflows, troubleshooting guidance, and protocol enhancements to maximize reproducibility and scientific impact in apoptosis, cell cycle, and tumor regression studies.

413 records 11/28 page Previous Next First page 上5页 1112131415 下5页 Last page